September/October 2024
Biopharma Asia
September/October 2024 | Volume 13 Issue 5
Continuous PAT for Downstream Manufacturing
Paul Gillham, Innovations Director, Optimal Industrial Technologies
Single Use Systems in Biologics Manufacturing and their Impact on Manufacturing Execution ...
Gloria Gadea-Lopez, Ph.D., Advisory Board Member, Carbon Biosciences, Head of Global Consu...
Endotoxins Standards and Their Role in Recovery Studies: The Path Forward
Karen Zink McCullough, MMI Associates Radhakrishna Tirumalai, Ph.D., United States Pharmac...
Bioreactor Process Improvements in a Perfusion-Based Process
Jiayi Zhang, Senior Director CMC, WuXi Biologics (Previously Manager, Process Development/...
Platform Purification of Six Biosimilar Molecules using Amsphere A3 – Protein A Resin
JSR Life Sciences
















